Pharma World Congress held in India for the First time in 100 years     Prez Calls Upon Pharma Industry To Check Manufacture Of Spurious Drugs    FIP President inaugurates PSM INDIA stall at the world pharma congress exhibition     Two arrested for selling govt hospital's medicines    China tightens oversight of CMOs to curb counterfeiting    New Zealand drug formulary launched   DCGI office hands over cases relating to sale of banned drugs to respective State authorities for prosecution    Probe ordered into expired drugs supply by UK NGO   Health Ministers from 11 Asian countries commit to rational use of antibiotics   Centre to launch revised pharmacopoeia soon  Chinese pharma company's licence cancelled over inspection  

 

 

In this issue

PSM INDIA Founder , Mr.Bejon Misra addresses the FIP symposium on Counterfeit Medicines

National News

Global News

Drug Laws and Policy News

Pharma News

 

   
 

DCGI office hands over cases relating to sale of banned drugs to respective State authorities for prosecution

New Delhi : Office of the Drug Controller General of India (DCGI) has asked the drug controllers of Maharashtra and Delhi to initiative prosecution against those found selling the banned drugs of rosiglitazone, gatifloxacin and tegaserod.

The teams comprising officials of the Central Drugs Standard Control Organisation (CDSCO) had raided 143 drug outlets including hospitals and chemist shops in Delhi, Bhiwadi in Rajasthan and in Maharashtra some time back and found the sale of banned drugs.

Some drugs like gatifloxacin formulation for systemic use in human by any route including oral and injectable and tegaserod and its formulations were banned by the Central Government by the Gazette Notification GSR 218(E) dated 16th March, 2011. Another drug namely rosiglitazone was banned earlier by the Gazette Notification GSR 910(E) dated 12.11.2010.

The DCGI had written to all State Drugs Controllers on 28.03.2011 to ensure that the manufacturing licences granted in their States for manufacture of the said drugs formulations are cancelled with immediate effect and the formulations recalled from the market on top priority. They were also asked to direct the chemists and druggists to stop the sale of these formulations with immediate effect and return the unused stocks to the manufacturers.

Source: Pharmabiz

 
 

 

 

Valuable feedback to THE EDITOR - Pooja Khaitan, pooja@jagograhakjago.com

Pooja Khaitan - Editor

© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065 jagograhakjago.com; jagograhakjago.com; Consumer Conexion